Alexander Mauskop

Alexander Mauskop

From The Departments Of Neurology And Epidemiology And Population Health (Dr. Lipton), Albert Einstein College Of Medicine, Bronx, And New York Headache Center (Dr. Mauskop), ...

Direct Impact

Concepts for which Alexander Mauskop has direct influence:

menstrual migraine
botulinum toxin
ionized magnesium
cluster headaches
chronic opioid therapy
trigeminal neuralgia
headache disorders

External impact

Concepts related to the work of other authors for which Alexander Mauskop has influence:

resource utilization
headache centers
cerebral ischemia
sumatriptan nasal spray
analgesic rebound
multicenter chart-review
migraine prescribed erenumab

Prominent publications by Alexander Mauskop

KOL-Index: 25 OBJECTIVE: Although a wide range of acute and preventative medications are now available for the treatment of migraine headaches, many patients will not have a significant improvement in the frequency and severity of their headaches unless lifestyle modifications are made. Also, given the myriad side effects of traditional prescription medications, there is an increasing demand for "natural" ...
Known for
Management Migraines | Medications Migraine | Role Foods | Supplements Preventative
KOL-Index: 17 BackgroundFremanezumab, a fully humanized monoclonal antibody (IgG2Δa) that selectively targets calcitonin gene-related peptide (CGRP), is approved for migraine prevention in adults. Real-world data on the effectiveness of fremanezumab are limited. This retrospective, observational cohort study assessed patient-reported migraine symptoms, health care resource utilization (HCRU), and direct ...
Known for
Patient-Reported Migraine Symptoms | Calcitonin Gene-Related Peptide | Integrated Services Database | ≥ 1 Month
KOL-Index: 16 Magnesium is an important intracellular element that is involved in numerous cellular functions. Deficiencies in magnesium may play an important role in the pathogenesis of migraine headaches by promoting cortical spreading depression, alteration of neurotransmitter release and the hyperaggregation of platelets. Given this multifaceted role of magnesium in migraine, the use of magnesium in ...
Known for
Migraine Discussed | Headache Intravenous | Oral Magnesium | Acute Preventive
KOL-Index: 16 Botulinum neurotoxin (BoNT) has been in clinical use for the treatment of headaches for over 15 years. Recent double-blind placebo-controlled trials have confirmed the efficacy of BoNT type A (onabtoulinumtoxinA, Botox) in the treatment of chronic migraine. The efficacy of BoNT in the treatment of episodic migraine headaches, cluster headaches, and chronic tension-type headache (TTH) has not ...
Known for
Episodic Migraine Headaches | Glutamate Calcitonin Gene-Related Peptide | Chronic Migraine | Bont Headache
KOL-Index: 16 Primary headache disorders, such as migraine, chronic daily headache (CDH), and chronic tension-type headache (CTTH), are some of the most frequent disorders encountered by physicians in the outpatient setting. Chronic headache disorders cause significant morbidity and functional impairment. Despite important advances in both pharmacological and behavioral management of headache disorders, a ...
Known for
Cdh Ctth | Headaches Botulinum
KOL-Index: 14 BACKGROUND: We sought to assess a novel, noninvasive, portable vagal nerve stimulator (nVNS) for acute treatment of migraine. METHODS: Participants with migraine with or without aura were eligible for an open-label, single-arm, multiple-attack study. Up to four migraine attacks were treated with two 90-second doses, at 15-minute intervals delivered to the right cervical branch of the vagus ...
Known for
30 Enrolled | 80 Attacks | Moderate Severe Pain | 19 21
KOL-Index: 14 OBJECTIVE: To describe the pain relief, satisfaction, and health-related quality of life results of moderate or severe migraines treated with a sumatriptan/naproxen sodium combination tablet. METHODS: Sumatriptan and naproxen sodium as a single-dose formulation tablet was used to treat moderate to severe migraines over a 12-month period in a phase 3, open-label, multicenter study (n = 565) ...
Known for
Satisfied Increased | Satisfaction Moderate | Remained Migraine
KOL-Index: 14 PURPOSE OF REVIEW: The efficacy of some nonpharmacologic therapies appears to approach that of most drugs used for the prevention of migraine and tension-type headaches. These therapies often carry a very low risk of serious side effects and frequently are much less expensive than pharmacologic therapies. Considering this combination of efficacy, minimal side effects, and cost savings, ...
Known for
Combination Nonpharmacologic | Exercise Acupuncture | Cyanocobalamin Folate | Supplementation Magnesium
KOL-Index: 13 Use of chronic opioid therapy for chronic noncancer pain has increased substantially. The American Pain Society and the American Academy of Pain Medicine commissioned a systematic review of the evidence on chronic opioid therapy for chronic noncancer pain and convened a multidisciplinary expert panel to review the evidence and formulate recommendations. Although evidence is limited, the ...
Known for
Formulate Recommendations | Management Opioid | Carefully Monitored | Breakthrough Pain
KOL-Index: 10 The use of botulinum toxin for movement disorders and cosmesis led to an accidental discovery of its beneficial effect on headaches. Extensive anecdotal evidence and several controlled trials suggest that intermittent and chronic migraines and chronic tension headaches may respond to this treatment. The effect of a single treatment, which is simple to administer, can last for 3 months. ...
Known for
Effects Botulinum | Toxin Systemic

From the Departments of Neurology and Epidemiology and Population Health (Dr. Lipton), Albert Einstein College of Medicine, Bronx, and New York Headache Center (Dr. Mauskop), New York, NY, and Innovative Medical Research, a Division of Advance PCS, B

https://www.g2.com/products/key-opinion-leaders-kols/reviews https://www.bbb.org/us/fl/doral/profile/data-analytics/key-opinion-leaders-0633-92023858 https://www.trustpilot.com/review/keyopinionleaders.com https://www.yelp.com/biz/key-opinion-leaders-miami


© 2022 - Key Opinion Leaders -
Key Opinion Leaders, LLC ,
2025 NW 102 Avenue, Suite 111 Doral , FL   33172